Understanding Your Laboratory Test: A Patient Guide
This blood or bone marrow test checks for a specific genetic mutation (c.944C>T) in the ABL1 gene that may affect leukemia treatment response.
{"Detects a specific genetic change (c.944C>T) in the ABL1 gene","Helps doctors determine if certain leukemia treatments will work","Requires a blood or bone marrow sample","Results guide personalized treatment decisions","Also known as T315I mutation, associated with treatment resistance"}
Key facts at a glance
- LOINC
- 95550-0
- Short code
- ABL1 c.944C>T
- Synonyms
- ABL1 c.944C>T Bld/Mar Ql
- Category
- chemistry
- Sample
- whole-blood
- Container
- EDTA tube (Lavender top - K2EDTA or K3EDTA)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–120 years
- Method
- molgen
- CPT
- 81206
- SNOMED
- 371468004
- Specimen volume
- 2-5 mL whole blood; 1-2 mL minimum acceptable
- Stability
- Room temperature: 24-72 hours; Refrigerated (2-8°C): up to 7 days; Frozen (-20°C or below): acceptable for extended storage but avoid repeated freeze-thaw cycles
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 72–168 hours
- Order
- routine
This test is a laboratory or diagnostic procedure that helps your doctor measure specific substances or check how certain parts of your body are working. The results provide important information about your overall health and help guide decisions about your care.
The ABL1 gene c.944C>T test is a molecular genetic test that looks for a specific mutation (change) in the ABL1 gene. This gene provides instructions for making a protein involved in cell growth and division. The c.944C>T mutation creates a specific change in the ABL1 protein (known as T315I), which can affect how certain cancer medications work.
Your doctor may order this test to look for a medical condition, monitor a health problem you already have, or see how well a treatment is working. It can also be part of a routine checkup to find potential issues early, before symptoms appear.
Your doctor may order this test if you have been diagnosed with leukemia, particularly chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). This test helps determine whether the leukemia cells carry the c.944C>T (T315I) mutation, which can make certain targeted therapies less effective. The results help your doctor choose the most appropriate treatment for your specific condition.
The test is usually performed by a trained healthcare professional in a clinic, hospital, or laboratory. Depending on the type of test, a small sample of blood, urine, or other body material may be collected, or a scanning device may be used. The procedure is typically quick and straightforward.
The test requires a sample of your blood or bone marrow. For a blood test, a healthcare provider will draw blood from a vein in your arm. For a bone marrow test, a small sample of liquid bone marrow is collected from your hip bone using a thin needle. The sample is then sent to a laboratory where scientists use specialized molecular techniques to look for the c.944C>T mutation in the ABL1 gene.
Your results will be compared with standard reference ranges. Values within the normal range usually suggest no abnormality, while values that are too high or too low may point to a condition that needs further evaluation. Your doctor will explain what your specific results mean and what the next steps may be.
Results are typically reported as 'Present' (mutation detected) or 'Absent' (mutation not detected). If the mutation is present, it may indicate that standard tyrosine kinase inhibitor (TKI) therapies like imatinib may not work as well. Your doctor will use this information, along with other test results and your overall health, to determine the best treatment plan. A negative result suggests that standard treatments may be more likely to be effective.
Most tests are very safe. If a blood sample is taken, you may feel a brief sting and notice slight bruising or soreness at the needle site. Serious complications are rare. Contact your doctor if you experience unusual pain, swelling, bleeding, or signs of infection afterward.
The risks associated with blood collection are minimal and may include slight pain, bruising, or bleeding at the needle site. Bone marrow collection may cause temporary discomfort or bruising at the collection site. These procedures are generally safe and are performed by experienced healthcare professionals.
Reference range
Not Detected / Absent - The c.944C>T variant in ABL1 gene should not be present in the germline DNAN/A
No special preparation required. Standard venipuncture precautions apply. Inform the laboratory of any recent blood transfusions as this may affect results.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
The ABL1 c.944C>T (T315I) mutation is clinically significant because it is associated with resistance to first-generation and second-generation tyrosine kinase inhibitors (TKIs) used to treat CML and Philadelphia chromosome-positive ALL. Detection of this mutation may lead to consideration of alternative treatments such as ponatinib, which is specifically active against the T315I mutation. This test is also important for monitoring disease progression and guiding treatment decisions throughout therapy.
Frequently asked questions
How long does it take to get results?
Do I need to fast before this test?
Can this test tell me if my cancer is cured?
Will I need to have this test again?
Does having this mutation mean my cancer is worse?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy